Mizuho Securities Reiterates Buy Rating on Evolus (EOLS) Following 3Q Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
Evolus Reports Third Quarter 2019 Financial Results and Provides Business Update
November 4, 2019 7:00 AM ESTJeuveau® Generated $13.2 Million in U.S. Net Revenue in Q3 2019; up from $2.3 Million in Q2 2019
J.E.T. Enrolled Accounts Drove 90% of Q3 Revenue
Jeuveau® Achieved Number Three Unit Share Position in the U.S. for Q3 20191
Nuceiva Approved in the European Union and Launched in Canada
NEWPORT BEACH, Calif., Nov. 04, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (Nasdaq: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today... More
